Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Doctors Slam FSSAI Inaction After Delhi HC Allows ORSL Sales, Warn of Child Health Risks

Farhat Nasim29 Oct 2025 7:27 PM IST

New Delhi: In a strong reaction after the Delhi High Court's interim order allowing JNTL Consumer Health India to continue selling ORSL-branded...

Emcure Pharma's Wellness Arm Arth Ropes In MS Dhoni to Promote Sleep Gummies Range

Farhat Nasim27 Oct 2025 7:17 PM IST

New Delhi: Arth by Emcure, a wellness brand from Emcure Pharmaceuticals, has partnered with former Indian cricket captain MS Dhoni for its new...

Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal

Farhat Nasim24 Oct 2025 11:36 AM IST

New Delhi: In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) and Cipla...

Dehradun Hospital License Suspended After Woman Dies From Retained Gauze Post C-Section, Probe Underway

Farhat Nasim23 Oct 2025 9:49 PM IST

Dehradun: The registration of a private MotherCare Hospital in Dehradun has been cancelled and its licence suspended after a 26-year-old woman, Jyoti...

Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara

Farhat Nasim23 Oct 2025 1:38 PM IST

Bengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that Health Canada has granted a Notice of Compliance (NOC) for...

Luxury Cars for Employees: This Pharma Firm's Diwali Giveaway Goes Viral

Farhat Nasim22 Oct 2025 9:22 PM IST

Chandigarh: A Chandigarh-based pharmaceutical company created a buzz ahead of Diwali by gifting 51 brand-new luxury cars and SUVs to its top...

Bengaluru Dermatologist Sent to Judicial Custody After 21-Year-Old Alleges Sexual Harassment During Skin Examination

Farhat Nasim21 Oct 2025 5:25 PM IST

Bengaluru: A dermatologist has been arrested for allegedly sexually harassing a 21-year-old woman during a consultation at his private clinic in...

Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales

Farhat Nasim10 Oct 2025 3:46 PM IST

New Delhi: In a remarkable rise, Eli Lilly's Mounjaro (tirzepatide) has become India's second-highest selling drug by value within just six months of...

Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol

Farhat Nasim30 Sept 2025 3:09 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Intas Pharmaceuticals Ltd. to...

Alembic Pharma wins USFDA nod for heart disease drug

Alembic Pharma Gets USFDA Nod for Generic Paxil CR Tablets

Farhat Nasim25 Sept 2025 4:06 PM IST

New Delhi: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) for...

Game-Changer for HIV: Dr Reddy's, Hetero to Sell Generic Lenacapavir at Rs 3,547 a Year

Farhat Nasim25 Sept 2025 3:51 PM IST

Bengaluru: Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and highly...

Sanofi Commits USD 625 Million to Sanofi Ventures to Boost Biotech and Digital Health Startups

Farhat Nasim25 Sept 2025 3:45 PM IST

New Delhi: Sanofi Ventures has announced a new USD 625 million multiyear capital commitment from Sanofi, increasing its total assets under management...

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok